These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 22369480

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Bicalutamide treatment for locally advanced prostate cancer.
    Anderson J.
    Hosp Med; 2000 Sep; 61(9):660-3. PubMed ID: 11048610
    [Abstract] [Full Text] [Related]

  • 23. Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience.
    Kobayashi M, Nukui A, Suzuki K, Kurokawa S, Morita T.
    Int J Clin Oncol; 2011 Dec; 16(6):630-6. PubMed ID: 21512893
    [Abstract] [Full Text] [Related]

  • 24. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
    Washino S, Hirai M, Saito K, Kobayashi Y, Arai Y, Miyagawa T.
    Low Urin Tract Symptoms; 2018 Jan; 10(1):57-63. PubMed ID: 27943566
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer.
    Akyol F, Selek U, Ozyigit G, Onal C, Akdogan B, Karabulut E, Ozen H.
    J Natl Med Assoc; 2006 Jul; 98(7):1058-61. PubMed ID: 16895273
    [Abstract] [Full Text] [Related]

  • 30. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
    Scher HI, Liebertz C, Kelly WK, Mazumdar M, Brett C, Schwartz L, Kolvenbag G, Shapiro L, Schwartz M.
    J Clin Oncol; 1997 Aug; 15(8):2928-38. PubMed ID: 9256137
    [Abstract] [Full Text] [Related]

  • 31. [Preliminary results of casodex use in patients with hormone-resistant cancer of the prostate].
    Matveev BP, Bukharkin BV.
    Urologiia; 2001 Aug; (6):20-1. PubMed ID: 11785074
    [No Abstract] [Full Text] [Related]

  • 32. Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.
    Moul JW.
    Cancer; 2009 Aug 01; 115(15):3376-8. PubMed ID: 19484788
    [No Abstract] [Full Text] [Related]

  • 33. Newer approaches to androgen deprivation therapy in prostate cancer.
    Pitts WR.
    Urology; 2003 Apr 01; 61(4):882. PubMed ID: 12670593
    [No Abstract] [Full Text] [Related]

  • 34. Japan Cancer of the Prostate Risk Assessment for combined androgen blockade including bicalutamide: clinical application and validation.
    Kitagawa Y, Hinotsu S, Shigehara K, Nakashima K, Kawaguchi S, Yaegashi H, Mizokami A, Akaza H, Namiki M.
    Int J Urol; 2013 Jul 01; 20(7):708-14. PubMed ID: 23216462
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
    Miyake H, Hara I, Eto H.
    BJU Int; 2005 Oct 01; 96(6):791-5. PubMed ID: 16153202
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer.
    See WA, Tyrrell CJ, CASODEX Early Prostate Cancer Trialists' Group.
    J Cancer Res Clin Oncol; 2006 Aug 01; 132 Suppl 1():S7-16. PubMed ID: 16896884
    [Abstract] [Full Text] [Related]

  • 40. Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
    Nishimura K, Arichi N, Tokugawa S, Yoshioka I, Kishikawa H, Ichikawa Y.
    Int J Urol; 2007 Mar 01; 14(3):264-7. PubMed ID: 17430272
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.